Nuclein's DASH® SARS-CoV-2 & Flu A/B Test Achieves FDA Clearance for Rapid Diagnosis Nuclein's DASH® SARS-CoV-2 & Flu A/B Test has obtained FDA 510(k) clearance and CLIA waiver, revolutionizing rapid diagnostic testing.

Nuclein's DASH® SARS-CoV-2 & Flu A/B Test Achieves FDA Clearance for Rapid Diagnosis #USA #Austin #Nuclein #CovarsaDx #DASH_Test